ADVM
Price
$2.81
Change
-$0.31 (-9.94%)
Updated
May 9 closing price
Capitalization
65.18M
KYMR
Price
$30.07
Change
-$0.70 (-2.27%)
Updated
May 9 closing price
Capitalization
2B
83 days until earnings call
Ad is loading...

ADVM vs KYMR

Header iconADVM vs KYMR Comparison
Open Charts ADVM vs KYMRBanner chart's image
Adverum Biotechnologies
Price$2.81
Change-$0.31 (-9.94%)
Volume$354.1K
Capitalization65.18M
Kymera Therapeutics
Price$30.07
Change-$0.70 (-2.27%)
Volume$535.92K
Capitalization2B
ADVM vs KYMR Comparison Chart
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. KYMR commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a StrongBuy and KYMR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (ADVM: $2.81 vs. KYMR: $30.07)
Brand notoriety: ADVM and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 115% vs. KYMR: 73%
Market capitalization -- ADVM: $65.18M vs. KYMR: $2B
ADVM [@Biotechnology] is valued at $65.18M. KYMR’s [@Biotechnology] market capitalization is $2B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ADVM and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 3 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • ADVM’s TA Score: 3 bullish, 5 bearish.
  • KYMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than ADVM.

Price Growth

ADVM (@Biotechnology) experienced а -19.48% price change this week, while KYMR (@Biotechnology) price change was -14.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

ADVM is expected to report earnings on Apr 15, 2025.

KYMR is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2B) has a higher market cap than ADVM($65.2M). KYMR YTD gains are higher at: -25.255 vs. ADVM (-39.829). ADVM has higher annual earnings (EBITDA): -99.25M vs. KYMR (-216.24M). KYMR has more cash in the bank: 489M vs. ADVM (153M). ADVM has less debt than KYMR: ADVM (73.3M) vs KYMR (87.8M). KYMR has higher revenues than ADVM: KYMR (47.1M) vs ADVM (1M).
ADVMKYMRADVM / KYMR
Capitalization65.2M2B3%
EBITDA-99.25M-216.24M46%
Gain YTD-39.829-25.255158%
P/E RatioN/AN/A-
Revenue1M47.1M2%
Total Cash153M489M31%
Total Debt73.3M87.8M83%
FUNDAMENTALS RATINGS
ADVM: Fundamental Ratings
ADVM
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADVMKYMR
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MUR21.860.48
+2.25%
Murphy Oil Corp
BEAM17.410.16
+0.93%
Beam Therapeutics
COP88.59-0.23
-0.26%
ConocoPhillips
TRML15.10-0.64
-4.07%
Tourmaline Bio
ZVIA2.67-0.41
-13.31%
Zevia PBC

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with IMNM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
-9.94%
IMNM - ADVM
45%
Loosely correlated
-3.24%
CCCC - ADVM
45%
Loosely correlated
-4.55%
KYMR - ADVM
44%
Loosely correlated
-2.27%
ETNB - ADVM
43%
Loosely correlated
-1.16%
TENX - ADVM
43%
Loosely correlated
-4.30%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-2.27%
CCCC - KYMR
63%
Loosely correlated
-4.55%
RCKT - KYMR
57%
Loosely correlated
-0.71%
IMNM - KYMR
56%
Loosely correlated
-3.24%
RVMD - KYMR
56%
Loosely correlated
-3.56%
NRIX - KYMR
55%
Loosely correlated
-1.45%
More